This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hawaii Biotech, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Steven A. Ogata
Introduction
Steven A. Ogata is a prominent inventor based in Kailua, Hawaii, known for his contributions to vaccine development. With a focus on public health, particularly in the area of viral infections, he has made significant strides in creating innovative solutions that are safe and effective for a wide range of populations.
Latest Patents
One of Ogata's notable patents is for a West Nile virus vaccine, comprising the WN-80E recombinant subunit protein. This vaccine represents a considerable advancement in the field, as it contains a recombinantly produced form of truncated West Nile virus envelope glycoprotein paired with an aluminum adjuvant. The formulation of this vaccine is deemed suitable for the general population, including individuals who are immunosuppressed, immunocompromised, or immunosenescent. Furthermore, it is recognized for its safety and efficacy for both healthy and at-risk populations. The vaccine may also include a pharmaceutically acceptable vehicle, enhancing its utility in clinical applicative settings.
Career Highlights
Steven A. Ogata is associated with Hawaii Biotech, Inc., where his innovative research and development on viral vaccines flourish. His commitment to advancing vaccine technologies is evident through his work and the impactful applications of his research. With only one patent under his name, Ogata has already demonstrated his capability to contribute significantly to medical science, particularly in the battle against infectious diseases.
Collaborations
At Hawaii Biotech, Inc., Ogata collaborates with esteemed colleagues, including Beth-Ann Coller and Vidya Pai. Their combined expertise in virology and vaccine development establishes a rich collaborative environment beneficial for innovative research and development.
Conclusion
Steven A. Ogata’s work in creating a West Nile virus vaccine reflects a dedicated approach to improving public health through innovative pharmaceuticals. His contributions not only represent technological advancements in vaccine efficacy and safety but also highlight the importance of collaboration in scientific research aimed at combating viral infections. As he continues his work, Ogata remains a key figure to watch in the realm of vaccine innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile